2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文讨论生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Blood Advances BLOOD ADV (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.2
53人评分
我要评分
声誉 8.8 影响力 6.1 速度 7.0 | |||||||||||||||||
| 期刊ISSN | 2473-9529 | 安装APP,查看期刊最新消息
| ||||||||||||||||
| E-ISSN | 2473-9537 | |||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||
| 实时影响因子 | 截止2026年9月20日:5.822 | |||||||||||||||||
| 2025-2026自引率 | 3.9%点击查看自引率趋势图 | |||||||||||||||||
| 五年IF (数据来源于网友提供) | 7.397数据由网友[钢琴3672]收集提供 | |||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||
| 期刊简介 |
| |||||||||||||||||
| 期刊官方网站 | https://www.journals.elsevier.com/blood-advances | |||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||
| 该期刊中国学者近期发文 - New | Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia Author: Hu, Xiaoxia; Zhao, Yeqian; Jiang, Chuanhe; Fan, Yamin; Shi, Jimin; Luo, Yi; Yu, Jian; Lai, Xiaoyu; Liu, Lizhen; Ye, Yishan; Liang, Jiehan; Huang, Xin; Zheng, Zhongzheng; Huang, He; Shi, Wei; Zhao, Yanmin Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 16, pp. 5607-5619. DOI: 10.1182/bloodadvances.2026020264 Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS Author: Zweegman, Sonja; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J.; Venner, Christopher P.; Braunstein, Marc; Pour, Ludek; Marti, Josep; Basu, Supratik; Cohen, Yael C.; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Liu, Weiping; Wang, Jianping; van Brummelen, Emilie; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Borgsten, Fredrik; Rowe, Melissa; Carson, Robin; Usmani, Saad Z Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 16, pp. 5594-5606. DOI: 10.1182/bloodadvances.2026019937 Glofitamab plus gemcitabine and oxaliplatin for relapsed/ refractory DLBCL: 3-year follow-up of STARGLO Author: Abramson, Jeremy S.; Townsend, William; Fox, Christopher P.; Ku, Matthew; Hertzberg, Mark; Huang, Hui-Qiang; Zhang, Huilai; Yoon, Dok Hyun; Kim, Won Seog; Abdulhaq, Haifaa; Herbaux, Charles; Zaucha, Jan M.; Zhang, Qing-Yuan; Chang, Hung; Liu, Yanyan; Cheah, Chan Yoon; Ghesquieres, Herve; Mulvihill, Estefania; Kesavan, Murali; Kallemeijn, Martine; Ta, Richard; Choeurng, Voleak; Belousov, Anton; Relf, James; Bottos, Alessia; Lundberg, Linda; Gregory, Gareth P Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 15, pp. 5367-5377. DOI: 10.1182/bloodadvances.2026019764 PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia Author: Qi, Jialei; Li, Wen; Dheenadayalan, Rashmi Priyadharshini; Yosifov, Deyan Yordanov; Drewes, Cosima; Wist, Martin; Wieczorek, Marcel; Schmid, Vera; Hobeika, Elias; Gao, Xiang; Endres, Sascha; Schneider, Christof; Riecke, Armin; Barth, Holger; Gierschik, Peter; Siebert, Reiner; Tausch, Eugen; Stilgenbauer, Stephan; Jebaraj, Billy Michael Chelliah Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 15, pp. 5185-5198. DOI: 10.1182/bloodadvances.2025019077 | |||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Blood Advances的语言要求,还能让Blood Advances编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Blood Advances编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||
| 通讯方式 | 2021 L ST NW, SUITE 900, WASHINGTON, USA, DC, 20036 | |||||||||||||||||
| 出版商 | American Society of Hematology | |||||||||||||||||
| 涉及的研究方向 | Medicine-Hematology | |||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | ||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||
| 年文章数 | 494点击查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 99.81% | |||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 94.94% | |||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) 中科院的全球OA期刊索引(OAJ) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2473-9529%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 网友分享经验: | |||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Blood Advances顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia Author: Hu, Xiaoxia; Zhao, Yeqian; Jiang, Chuanhe; Fan, Yamin; Shi, Jimin; Luo, Yi; Yu, Jian; Lai, Xiaoyu; Liu, Lizhen; Ye, Yishan; Liang, Jiehan; Huang, Xin; Zheng, Zhongzheng; Huang, He; Shi, Wei; Zhao, Yanmin Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 16, pp. 5607-5619. DOI: 10.1182/bloodadvances.2026020264 PubMed DOI |
| 2. | Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS Author: Zweegman, Sonja; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J.; Venner, Christopher P.; Braunstein, Marc; Pour, Ludek; Marti, Josep; Basu, Supratik; Cohen, Yael C.; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Liu, Weiping; Wang, Jianping; van Brummelen, Emilie; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Borgsten, Fredrik; Rowe, Melissa; Carson, Robin; Usmani, Saad Z Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 16, pp. 5594-5606. DOI: 10.1182/bloodadvances.2026019937 PubMed DOI |
| 3. | Glofitamab plus gemcitabine and oxaliplatin for relapsed/ refractory DLBCL: 3-year follow-up of STARGLO Author: Abramson, Jeremy S.; Townsend, William; Fox, Christopher P.; Ku, Matthew; Hertzberg, Mark; Huang, Hui-Qiang; Zhang, Huilai; Yoon, Dok Hyun; Kim, Won Seog; Abdulhaq, Haifaa; Herbaux, Charles; Zaucha, Jan M.; Zhang, Qing-Yuan; Chang, Hung; Liu, Yanyan; Cheah, Chan Yoon; Ghesquieres, Herve; Mulvihill, Estefania; Kesavan, Murali; Kallemeijn, Martine; Ta, Richard; Choeurng, Voleak; Belousov, Anton; Relf, James; Bottos, Alessia; Lundberg, Linda; Gregory, Gareth P Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 15, pp. 5367-5377. DOI: 10.1182/bloodadvances.2026019764 PubMed DOI |
| 4. | PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia Author: Qi, Jialei; Li, Wen; Dheenadayalan, Rashmi Priyadharshini; Yosifov, Deyan Yordanov; Drewes, Cosima; Wist, Martin; Wieczorek, Marcel; Schmid, Vera; Hobeika, Elias; Gao, Xiang; Endres, Sascha; Schneider, Christof; Riecke, Armin; Barth, Holger; Gierschik, Peter; Siebert, Reiner; Tausch, Eugen; Stilgenbauer, Stephan; Jebaraj, Billy Michael Chelliah Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 15, pp. 5185-5198. DOI: 10.1182/bloodadvances.2025019077 PubMed DOI |
| 5. | ENO1 promotes acute myeloid leukemia progression through SCD1-mediated lipid metabolism reprogramming Author: Wu, Yijun; Gao, Li; Fang, Fang; Li, Zhiheng; Hu, Yixin; Zhang, Yongping; Yang, Chenwei; Wei, Zhongling; Liu, Xin; Yang, Ying; Zhang, Fenli; Zhang, Weiliang; Sun, Kaixuan; Li, Yizhen; Yang, Chun; Pan, Jian; Hu, Shaoyan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 14, pp. 4975-4990. DOI: 10.1182/bloodadvances.2025017973 PubMed DOI |
| 6. | Successful gene therapy for transfusion-dependent α-thalassemia: a case report Author: Yin, Xiaolin; Qian, Linxia; Dong, Guoyi; Chen, Yue; Zhou, Yali; Yang, Beibei; Liao, Guiping; Sun, Haigang; Guo, Honglian; Zeng, Xinru; Zou, Huilin; Ye, Ting; He, Jiajun; Yao, Wenwen; Ouyang, Wenjie; Zhang, Xinhua; Liu, Chao Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 14, pp. 5153-5160. DOI: 10.1182/bloodadvances.2025019280 PubMed DOI |
| 7. | PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells Author: Xiao, Shiyu; Kobayashi, Michihiro; Bai, Yunpeng; Cai, Wenjie; Barajas, Sergio; Amin, Mohammed Abdullahel; Vemula, Sasidhar; Yao, Chonghua; Yang, Yuxia; Borchers, Christopher; Mays, Tiffany M.; Sotelo, Magdalena; Pan, Hao; Jia, Yuzhi; Shen, Jian; Hu, Sophie K.; Ali, Moiez; Veranga, Sophia; Ogino, Jayme; Eggleston, Sydney G.; Liu, Huiping; Perlman, Harris R.; Li, Loretta S.; Altman, Jessica K.; Abaza, Yasmin; Eklund, Elizabeth A.; Ji, Peng; Zhang, Christine R.; Khan, Irum; Mayo, Lindsey D.; Mulloy, James C.; Sukhanova, Madina; Dou, Yali; Platanias, Leonidas C.; Zhang, Zhong-Yin; Chen, Hongxia; Liu, Yan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 13, pp. 4468-4482. DOI: 10.1182/bloodadvances.2025018908 PubMed DOI |
| 8. | The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study Author: Gill, Harinder; Yacoub, Abdulraheem; Gerds, Aaron T.; Shortt, Jake; Rossetti, James M.; Mead, Adam J.; Gothert, Joachim R.; Koschmieder, Steffen; Ewing, Joanne; Halpern, Anna B.; Palandri, Francesca; Passamonti, Francesco; Mesa, Ruben; Marchetti, Monia; Harrison, Claire; Vannucchi, Alessandro M.; Watts, Justin M.; Wood, John C.; Ross, David M.; Peppe, Jennifer; Natsoulis, Georges; Rienhoff Jr, Hugh Young Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 13, pp. 4585-4594. DOI: 10.1182/bloodadvances.2025018141 PubMed DOI |
| 9. | Metabolic profiling and perturbations of human CD34+hematopoietic stem and progenitor cells to regulate HSPC function Author: Yuan, Kai; Xiong, Mingfang; Yang, Rong; Sun, Keyu; Zhang, Zheng; Zhang, Shiwei; Xiu, Yanyu; Cai, Bo; Yang, Jing; Ju, Yan; Yin, Hongyu; Liang, Fei; Sun, Yuying; Zhao, Guangyu; Zeng, Yang Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 13, pp. 4798-4813. DOI: 10.1182/bloodadvances.2025018876 PubMed DOI |
| 10. | BCMA/CD19 dual-targeting CAR T-cell therapy in older patients with newly diagnosed multiple myeloma: a phase 1 study Author: Liu, Jin; Fan, Xiaoqiang; Peng, Liying; Liu, Jia; He, Haiyan; Qiang, Wanting; Jin, Lina; Shi, Lang; Lu, Jing; Guo, Pei; Shah, Nina; Zhang, Qi; Shen, Lianjun; Du, Juan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 12, pp. 4134-4143. DOI: 10.1182/bloodadvances.2025019036 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共1条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室